Terry Kohler - Jul 16, 2021 Form 3 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Role: Chief Financial Officer
Signature: /s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol: VRCA
Transactions as of: Jul 16, 2021
Transactions value $: $0
Form type: 3
Date filed: 7/20/2021, 05:59 PM
Next filing: Feb 25, 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney